Skip to content
Maui Sky – Lifestyle
Author:
CVRx, Inc.
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
September 29, 2026
CVRx Appoints John Landry as Chief Financial Officer
September 22, 2026
CVRx Responds to Letter from Pointillist Family Office
August 29, 2026
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
August 29, 2026
CVRx Announces Sales Leadership Transition
August 11, 2026
CVRx Reports Second Quarter 2026 Financial and Operating Results
August 6, 2026
CVRx to Present at Canaccord Genuity’s 46th Annual Growth Conference
July 28, 2026
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
July 23, 2026
CVRx Announces Chief Financial Officer Transition
June 9, 2026
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 27, 2026
1
2
Next Page
→